Angiodynamics reports fiscal 2021 first quarter financial results

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced financial results for the first quarter of fiscal year 2021, which ended august 31, 2020. “we had a strong first quarter, as our customers continued to show signs of recovery from the disruption of covid-19,” commented jim clemmer, president and chief executive officer of angiodynam
ANGO Ratings Summary
ANGO Quant Ranking